TEVA PHARMACEUTICAL INDUSTRIES LIMITED Debt Instrument, Fair Value Disclosure
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Debt Instrument, Fair Value Disclosure of $16.59 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-07-29
- 2026-06-30: Debt Instrument, Fair Value Disclosure $16.59B.
- 2026-03-31: Debt Instrument, Fair Value Disclosure $16.46B.
- 2025-12-31: Debt Instrument, Fair Value Disclosure $16.93B.
- 2025-09-30: Debt Instrument, Fair Value Disclosure $16.83B.
| Period end | Debt Instrument, Fair Value Disclosure | Debt Instrument, Fair Value Disclosure as first filed |
|---|---|---|
| 2026-06-30 | $16.59B 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $16.46B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $16.93B 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $16.83B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $17.13B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $16.36B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $17.50B 10-K · filed 2026-02-03 | |
| 2024-09-30 | $18.70B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $17.89B 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $18.84B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $18.86B 10-K · filed 2025-02-05 | |
| 2023-09-30 | $17.60B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $18.87B 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $19.02B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $18.77B 10-K · filed 2024-02-12 | |
| 2022-09-30 | $18.26B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $19.18B 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $21.93B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $22.90B 10-K · filed 2023-02-10 | |
| 2021-09-30 | $23.43B 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $25.00B 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $25.03B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $25.89B 10-K · filed 2022-02-09 | |
| 2020-09-30 | $24.16B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $24.73B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $23.54B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $25.00B 10-K · filed 2021-02-10 | |
| 2019-09-30 | $22.03B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $25.49B 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $26.35B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $25.70B 10-K · filed 2020-02-21 | |
| 2018-09-30 | $27.39B 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $27.53B 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $27.61B 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $26.17B 10-K · filed 2019-02-19 | |
| 2016-12-31 | $27.02B 10-K · filed 2018-02-12 | -$27.02B 20-F · filed 2017-02-15 |
| 2015-12-31 | -$9.08B 20-F · filed 2017-02-15 | |
| 2014-12-31 | -$9.51B 20-F · filed 2016-02-11 |